ACHFF
Price:
$0.353
Market Cap:
$34.65M
Arch Biopartners Inc. is a biotechnology company focused on developing innovative technologies with significant medical and commercial potential. Their primary endeavor involves advancing Metablok, a lead drug candidate designed to treat or prevent dipeptidase-1 (DPEP-1) mediated inflammation in critical organs like the lungs, liver, and kidneys. This inflammation is a key factor in organ damage or failure, often seen in severe conditions such as sepsis and COVID-19. Additionally, the company is progressing with AB569, an investigational drug aimed at combating or deterring antibiotic-resistant bacterial infections, predominantly through topical application for wounds. Further expanding thei...[Read more]
Industry
Biotechnology
IPO Date
2002-04-24
Stock Exchange
OTC
Ticker
ACHFF
According to Arch Biopartners Inc.’s latest financial reports and current stock price. The company's current ROE is 70.15%. This represents a change of 294.10% compared to the average of 17.80% of the last 4 quarters.
The mean historical ROE of Arch Biopartners Inc. over the last ten years is 148.51%. The current 70.15% ROE has changed -52.76% with respect to the historical average. Over the past ten years (40 quarters), ACHFF's ROE was at its highest in in the June 2018 quarter at 541.24%. The ROE was at its lowest in in the June 2021 quarter at -18.20%.
Average
148.51%
Median
81.15%
Minimum
30.14%
Maximum
397.41%
Discovering the peaks and valleys of Arch Biopartners Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.72%
Maximum Annual ROE = 397.41%
Minimum Annual Increase = -167.02%
Minimum Annual ROE = 30.14%
| Year | ROE | Change |
|---|---|---|
| 2025 | 40.00% | -55.63% |
| 2024 | 90.16% | 49.32% |
| 2023 | 60.38% | 91.72% |
| 2022 | 31.49% | 4.51% |
| 2021 | 30.14% | -74.82% |
| 2020 | 119.67% | 65.91% |
| 2019 | 72.13% | -76.41% |
| 2018 | 305.80% | -9.51% |
| 2017 | 337.94% | -14.96% |
| 2016 | 397.41% | -167.02% |
The current ROE of Arch Biopartners Inc. (ACHFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
63.52%
5-year avg
50.44%
10-year avg
148.51%
Arch Biopartners Inc.’s ROE is less than MindMaze Therapeutics Holding S.A. (0%), greater than Amplia Therapeutics Limited (-18.71%), greater than PsyBio Therapeutics Corp. (-867.29%), greater than Oncotelic Therapeutics, Inc. (0.00%), less than MindMaze Therapeutics Holding S.A. Sponsored ADR (0%), greater than Helix BioPharma Corp. (-21.54%), less than Covalon Technologies Ltd. (5.72%), greater than Speakeasy Cannabis Club Ltd. (-16.76%), less than ZIVO Bioscience, Inc. (353.53%), less than Vicapsys Life Sciences, Inc. (14.08%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $4.72M | |
| -18.71% | $42.09M | |
| -867.29% | $1.27K | |
| 0.00% | $22.22M | |
| 0% | $5.30M | |
| -21.54% | $130.61M | |
| 5.72% | $42.53M | |
| -16.76% | $1.31K | |
| 353.53% | $14.27M | |
| 14.08% | $47.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arch Biopartners Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arch Biopartners Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Arch Biopartners Inc.'s ROE?
How is the ROE calculated for Arch Biopartners Inc. (ACHFF)?
What is the highest ROE for Arch Biopartners Inc. (ACHFF)?
What is the 3-year average ROE for Arch Biopartners Inc. (ACHFF)?
What is the 5-year average ROE for Arch Biopartners Inc. (ACHFF)?
How does the current ROE for Arch Biopartners Inc. (ACHFF) compare to its historical average?